Rallybio RLYB
NASDAQ RLYB
$17.08 +0.32 (+1.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rallybio (RLYB) Price to Sales (2024 - 2026)

Updated

Rallybio's (RLYB) Price to Sales was 131.44 for Q2 2026, up 610.6% from 18.50 a year earlier and up 137.7% from the prior quarter.

Analysis

Rallybio (RLYB) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Rallybio was 33.81, down 46.0% from FY2024.

  • By year, Price to Sales came in at 62.66 in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Price to Sales since Q2 2024.
  • Year over year, Price to Sales gained in two of the last five quarters, with growth averaging 97.0%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 55.31 (Q1 2026), 33.81 (Q4 2025) and 31.03 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Rallybio 90.64 Mn 90.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 131.44
Mar 31, 2026 55.31
Dec 31, 2025 33.81
Sep 30, 2025 31.03
Jun 30, 2025 18.50
Mar 31, 2025 32.14
Dec 31, 2024 62.66
Sep 30, 2024 81.17
Jun 30, 2024 185.93
API Access

Rallybio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=RLYB&period=max&api_key=YOUR_API_KEY